0001104659-20-027395.txt : 20200228
0001104659-20-027395.hdr.sgml : 20200228
20200228212955
ACCESSION NUMBER: 0001104659-20-027395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAMPROPOULOS FRED P
CENTRAL INDEX KEY: 0000901534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18592
FILM NUMBER: 20673969
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000856982
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 870447695
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 WEST MERIT PARK WAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 8012531600
MAIL ADDRESS:
STREET 1: 1600 WEST MERIT PARKWAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
4
1
a4.xml
4
X0306
4
2020-02-26
0
0000856982
MERIT MEDICAL SYSTEMS INC
MMSI
0000901534
LAMPROPOULOS FRED P
1600 W MERIT PARKWAY
SOUTH JORDAN
UT
84095
1
1
0
0
President & CEO
Common Stock, No Par Value
95285
I
By 401(k) Plan
Common Stock, No Par Value
90
I
By spouse as custodian for child.
Common Stock, No Par Value
1269
I
By spouse.
Common Stock, No Par Value
929991
D
Non-qualified stock options (right to buy)
12.06
2015-10-04
2021-10-04
Common Stock
50000
50000
D
Non-qualified stock options (right to buy)
17.27
2016-02-13
2022-02-13
Common Stock
50000
50000
D
Non-qualified stock options (right to buy)
17.27
2016-02-13
2022-02-13
Common Stock
5000
5000
I
Please refer to footnote number four.
Non-qualified stock options (right to buy)
16.05
2017-01-28
2023-01-28
Common Stock
50000
50000
D
Non-qualified stock options (right to buy)
16.05
2017-01-28
2023-01-28
Common Stock
7500
7500
I
Please refer to footnote number four.
Non-qualified stock options (right to buy)
28.2
2018-04-14
2029-04-14
Common Stock
200000
200000
D
Non-qualified stock options (right to buy)
28.2
2018-04-14
2029-04-14
Common Stock
10000
10000
I
Please refer to footnote number four.
Non-qualified stock options (right to buy)
44.8
2019-03-02
2025-03-02
Common Stock
38002
38002
D
Non-qualified stock options (right to buy)
44.8
2019-03-02
2025-03-02
Common Stock
10000
10000
I
Please refer to footnote number six.
Non-qualified stock options (right to buy)
55.73
2020-03-01
2026-03-01
Common Stock
159151
159151
D
Non-qualified stock options (right to buy)
55.73
2020-03-01
2026-03-01
Common Stock
10000
10000
I
Please refer to footnote number four.
Non-qualified stock options (right to buy)
37.71
2020-02-26
4
A
0
100334
0
A
2021-02-26
2027-02-26
Common Stock
100334
100334
D
Performance Stock Units
2020-02-26
4
A
0
21215
0
A
2021-03-15
2023-03-15
Common Stock
21215
21215
D
Represents plan holdings as of 2/26/2020.
Becomes exercisable in equal annual installments of 20% commencing 10/4/2015.
Becomes exercisable in equal annual installments of 20% commencing 2/13/2016.
Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.
Becomes exercisable in equal annual installments of 20% commencing 1/28/2017.
Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria.
On February 26, 2020, the reporting person was awarded a target number of performance share units ("PSUs") pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement.
If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement.
Brian G. Lloyd, Attorney-in-Fact
2020-02-28